Deborah Geraghty has been appointed president and CEO of Radiant Biotherapeutics
Karen Roman
Toronto-based Biotech Company Radiant Biotherapeutics has announced its designation of Dr. Deborah Geraghty as president and CEO.
The company also appointed Dr. Stephen Larson as chairman of the board and appointed Ingmar Brands, MD and PhD as a member of the board, in a statement.
Dr. Geraghty leads a biopharmaceutical company with more than 20 years of financial, operational and strategic experience, and she is the former president and CEO of Anokion SA, the company said.
Dr. Larson serves on a diverse biotechnology board, including Prilenia Therapeutics and Apnimed, while Dr. Bruns is Zentalis’ Chief Medical Officer.
“Dr. Geraty has introduced a track record of building and transforming innovative biotech companies and is pleased to welcome her to shine,” Dr. Larson said. “Her deep industry expertise and strategic vision make her an ideal CEO who will guide her shine through this next phase of growth.”
Find out more from Healthcare Edge
The rising Pharma name CFO & SVP’s global corporate development and finance
Sign up for our weekly newsletter here
contact:
click here Follow us on LinkedIn